The global transcriptional coactivators CREB-binding protein (CBP) and the closely related p300 interact with over 312 proteins, making them among the most heavily connected hubs in the known mammalian protein-protein interactome. It is largely uncertain, however, if these interactions are important in specific cell lineages of adult animals, as homozygous null mutations in either CBP or p300 result in early embryonic lethality in mice. Here we describe a Cre/LoxP conditional p300 null allele (p300 flox ) that allows for the temporal and tissue-specific inactivation of p300. We used mice carrying p300 flox and a CBP conditional knockout allele (CBP flox ) in conjunction with an Lck-Cre transgene to delete CBP and p300 starting at the CD4 ؊ CD8 ؊ double-negative thymocyte stage of T-cell development. Loss of either p300 or CBP led to a decrease in CD4 ؉ CD8 ؉ double-positive thymocytes, but an increase in the percentage of CD8 ؉ single-positive thymocytes seen in CBP mutant mice was not observed in p300 mutants. T cells completely lacking both CBP and p300 did not develop normally and were nonexistent or very rare in the periphery, however. T cells lacking CBP or p300 had reduced tumor necrosis factor alpha gene expression in response to phorbol ester and ionophore, while signal-responsive gene expression in CBP-or p300-deficient macrophages was largely intact. Thus, CBP and p300 each supply a surprising degree of redundant coactivation capacity in T cells and macrophages, although each gene has also unique properties in thymocyte development.
CREB-binding protein (CBP) (Crebbp) and p300 (Ep300) are ubiquitously expressed ϳ2,400-residue nuclear phosphoproteins that share 61% overall sequence identity (ϳ80 to 90% in evolutionarily conserved domains). Homologs of CBP and p300 are found in Drosophila melanogaster and Caenorhabditis elegans, but there are no other closely related family members in mammals. These two coactivators typically bind to the activation domains of transcription effectors via five unique protein-binding domains (nuclear hormone receptor binding domain, CH1, KIX, CH3, and SID/IBiD) (64, 92) . CBP and p300 appear to function redundantly in many instances, but they also have unique properties, particularly in vivo (92) . The lack of other closely related family members or conservation of these protein-binding domains in other mammalian proteins implies that CBP and p300 are indispensable.
Following recruitment by transcription factors, juxtaposition of the adaptor, acetyltransferase, and ubiquitin ligase functions of CBP and p300 at the promoter/enhancer is hypothesized to stimulate target gene transcription (92) . Histones are believed to be the main acetylation targets of CBP and p300, thereby alleviating repressive chromatin and potentiating transcription, but the ability of CBP and p300 to regulate transcription factor activity by acetylation of specific lysine residues is also thought to be crucial (27, 176, 184) . The importance of CBP and p300 for the transcription of endogenous genes, however, has not been widely investigated.
An astonishingly large fraction of the estimated 1,962 (human) transcriptional regulators (134) , as well as other proteins, have been shown to interact physically and functionally with CBP and p300 (described interactions now total at least 312) ( Fig. 1 ; more detailed and up to date information is available at http://www.stjude.org/brindle). This number of interactions puts CBP and p300 at the top end of known "connectivity" in the interactome, as high-throughput screens to identify Drosophila, C. elegans, and mammalian interactome networks indicate that only a very small fraction of proteins have as many as 100 to 200 interacting partners (8, 60, 118) . It may even be inferred that CBP and p300 interact with the great majority of transcriptional regulators, as most have not been tested. More than half (Ͼ190) of the described CBP/p300 interactors are encoded by essential genes in mice ( Fig. 1) , thus the common assumption that loss of CBP or p300 will have catastrophic effects on specific cell lineages because of broad alterations in gene expression appears reasonable. Also implicit from the high level of connectivity for CBP and p300 is that cells cannot exist in the absence of both coactivators, although it has not been possible to test this rigorously because a conditional knockout allele for p300 has not been available.
It is generally thought that CBP and p300 together are present in limiting amounts in cells, consistent with the view that they are widely involved in transcription (64, 115, 203) . Mice that are homozygous for CBP and p300 null alleles, or doubly heterozygous, die during embryogenesis, providing strong evidence for this notion (190, 223) . Mice and humans that are haploinsufficient for CBP have developmental defects, also consistent with models that invoke limiting levels of CBP (203) . The fact that CBP Ϫ/Ϫ and p300 Ϫ/Ϫ mice survive until about embryonic day 9 (E9), however, shows that many cell types can develop and survive with only CBP or p300.
The roles of CBP and p300 in blood cells are of considerable interest because they are thought to be vital for the function of many hematopoietic transcription factors; at least 65 factors that interact with CBP or p300 are encoded by genes that are essential for T and B cells in mice (Fig. 1) . Moreover, chromosomal translocations involving CBP or p300 produce gainof-function fusion proteins in some types of human leukemia (18) (Fig. 1) . Both CBP and p300 are necessary for normal definitive hematopoiesis, including lymphopoiesis, in chimeric FIG. 1. The CBP and p300 interactome: 312 viral and mammalian proteins that interact physically or functionally with CBP or p300 in vitro. One hundred ninety-six proteins that are encoded by essential genes in mice (i.e., mutation results in a phenotype) are indicated in boldface type, including 56 genes that are essential for T cells (indicated by an asterisk). The source for phenotype information is Mouse Genome Informatics (http://www.informatics.jax.org/). For more detailed and up to date information on the interactome, see http://www.stjude.org/brindle. References are indicated in parentheses.
mice created with CBP Ϫ/Ϫ or p300 Ϫ/Ϫ embryonic stem cells (164) . CBP can also act as a tumor suppressor in hematopoietic cells, including T cells (93) , tissue macrophages (histiocytes), and possibly the B-cell lineage (plasmacytomas developed in mice transplanted with CBP heterozygous cells) (109) . There is less evidence for p300 acting as a tumor suppressor in hematopoietic cells, although histiocytic sarcoma has been reported in p300 Ϫ/Ϫ chimeric mice (164) . Still, peripheral blood T-cell numbers appear to be mostly unaffected in CBP and p300 heterozygous mice (109) , even though CBP and p300 have been implicated by a number of studies as being important for the activity of 56 T-cell-critical transcriptional regulators (Fig.  1) . In this regard, conditional knockout of CBP in multiple cell lineages that include thymocytes leads to abnormally high levels of CD8 ϩ single-positive (SP) thymocytes (93) . In addition, mice that are homozygous for mutations in the CREB-and c-Myb-binding domain (KIX) of p300 have thymic hypoplasia in the context of multilineage hematopoietic defects (95) . It is uncertain, however, if CBP and p300 function equivalently in T-cell development. To test the hypothesis that CBP and p300 are each critically limiting in specific cell lineages in vivo, we developed mice with conditional knockout alleles for each gene. We then examined the requirement for CBP and p300 in thymocyte development and their roles in T-cell and macrophage gene expression.
MATERIALS AND METHODS

Generation of p300
flox mice. The p300 flox allele was constructed by flanking exon 9 of the mouse Ep300 gene with LoxP sites. DNA for the targeted region was obtained from an E14 Ola mouse embryonic stem (ES) cell genomic DNA phage library. A LoxP site was inserted in the intron 3Ј of exon 9 using a Tn7 transposon-based system (GPS mutagenesis system, catalog no. 7101; New England Biolabs) with a modified mini-Tn7 vector (pGPS3-PM30-R 1-70 -Neo-CAT-TK no. 2; details available upon request) that allowed random insertion of a LoxP site and a selection cassette containing genes for neomycin resistance (Neo), chloramphenicol resistance, and thymidine kinase (TK) flanked by Frt sites (16, 135) . A second LoxP site was inserted in the intron 5Ј of exon 9 using the Tn7 system and another modified mini-Tn7 vector (pGPS3-CAT-R 1-70 -LoxP no. 2; details available upon request) (16) . In addition, a diphtheria toxin A cassette placed at the 3Ј end of the targeting construct provided negative selection to reduce the number of nonhomologous targeting events. Mouse ES cells were electroporated with linearized targeting construct and cultured with G418 to positively select for clones that had integrated the targeting construct. Clones were screened by PCR across the 3Ј end of the targeted region, and positive clones were confirmed by Southern blotting using a StuI digest with a 5Ј external probe as well as an Asp718/SpeI digest with a 3Ј external probe to check for homologous targeting. To remove the drug selection cassette, correctly targeted clones were subjected to transient expression of Flp recombinase and treated with 2Ј-fluoro-2Ј-deoxy-5-iodouracil-␤-D-arabinofuranoside (FIAU) to enrich for clones that had lost the TK gene (169) . Recombination of the Frt sites was confirmed by PCR, and positive clones were checked for loss of the selection cassette by Southern blotting using an XbaI digest and a probe for Neo.
Genotyping of mice. p300 and CBP conditional knockout mice were bred to Lck-Cre transgenic mice (69) or lysM-Cre transgenic mice (32). Recombination of the LoxP sites flanking p300 exon 9 in cells expressing Cre was determined by Southern blotting using an XbaI or EcoRI digest and a cDNA probe to the region encoding amino acids 615 to 681 or by semiquantitative PCR using primers p4 (CTCTACATCCTAAGTGCTAGG), p5 (TGGACTGGTTATCGG TTCACC), and p6 (CAGTAGATGCTAGAGAAAGCC), producing a 540-bp wild-type band, a 720-bp p300 flox band and a 1.1-kb p300 ⌬flox band (primer locations shown in Fig. 2 ). This semiquantitative PCR overestimates the deletion of the p300 flox allele in a systematic manner that was corrected for by using a standard curve of samples of known deletion as determined by quantitative Southern blotting. Generation of CBP conditional knockout mice and PCR genotyping for the deletion of the CBP flox allele was reported by Kang-Decker et al. (93) . Detection of the flox and ⌬flox alleles of CBP by Southern blotting was performed using a HindIII digest and a 5Ј external probe. Thymocyte subpopulations were sorted to check deletion by flow cytometry using anti-CD4 and anti-CD8 antibodies. T cells from the spleen and lymph node were purified to check deletion by positive selection using anti-Thy1.2-conjugated magnetic beads from Miltenyi Biotech.
Indirect immunofluorescent staining, nuclear extracts, and Western blots. Antibodies against CBP (A-22 and C-20) and p300 (N-15 and C-20) for immunofluorescence and Western blotting were from Santa Cruz. Indirect immunofluorescent detection of CBP and p300 was performed as previously described using single-cell suspensions of thymus and anti-p300 (1:800 dilution, C-20) and anti-CBP (1:800, C-20) antibodies (93) . Nuclear extract preparations and Western blots were performed as previously described (95) .
Flow cytometry and complete blood count. Antibodies for flow cytometry (fluorescence-activated cell sorting [FACS] ) analysis (anti-CD3, anti-CD4, anti-CD8, anti-B220) were purchased from Becton Dickenson. FACS was performed on a FACSCalibur system using CellQuest software. Automated complete blood counts were performed using a Hemavet 3700R.
Estimation of total cell counts. Total counts for thymic subpopulations were determined by multiplying the percentage of cells in a subpopulation as measured by FACS by the total manual viable thymocyte count for that mouse. Cell counts in peripheral blood were estimated from automated complete blood count lymphocyte count per microliter multiplied by the percentages of T cells and B cells in peripheral blood as determined from anti-CD3 versus anti-B220 FACS.
Bone marrow-derived macrophages. Bone marrow-derived macrophages (BMDMs) were obtained by flushing bone cavities and isolating macrophages by differentiation in L-cell-conditioned medium as a source of macrophage colonystimulating factor as described previously (141) .
Activation of splenic T cells and qRT-PCR. Splenic T cells were sorted by FACS and cultured at 2 ϫ 10 6 cells/ml in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum with 1 ng/ml phorbol myristate acetate (PMA) and 100 ng/ml ionomycin or dimethyl sulfoxide vehicle for 3 h at 37°C in roundbottom plates. cDNA was generated from 100 ng of total RNA in a 20-l reaction mixture using Superscript II reverse transcriptase (RT; Invitrogen). Quantitative RT-PCR (qRT-PCR) was performed on an Opticon DNA engine (MJ Research) using 1 l of cDNA per 25 l PCR with SYBR green dye. qPCR primers were designed using Primer Express software (Applied Biosystems) and confirmed to yield a single product by melting curve analysis. Samples were normalized to GAPDH mRNA.
RESULTS
Creation of mice with a p300 Cre/LoxP conditional knockout allele. Mouse genomic DNA harboring p300 exons encoding the CREB-binding domain (KIX) was used in the targeting construct. Two LoxP sites were inserted into the introns flanking exon 9, encoding residues 588 to 626 (Fig. 2a) ; Cre-mediated recombination results in a frameshift mutation if the flanking exons fortuitously splice and a stable mRNA is produced. The equivalent exon is targeted in the CBP flox allele, so the p300 flox allele is a comparable experimental system (93). Neomycin-resistant ES cell clones were confirmed for correct targeting of the p300 locus by Southern blotting using 5Ј and 3Ј probes that were external to the targeting construct (Fig. 2b) (L. H. Kasper, data not shown). The Frt site-flanked drug selection cassette was removed in the ES cells by transient expression of Flp recombinase. Chimeric mice were generated by standard methods, and germ line transmission of the p300 flox allele was achieved. Importantly, p300 flox/flox homozygous mice appeared normal, indicating that the conditional allele is indistinguishable from the wild type in the absence of Cre recombinase. p300 flox recombination in the presence of Cre (yielding p300 ⌬flox ) was efficient, although it showed considerable variation between mice carrying the Lck-Cre transgene (Fig. 2b) . This is likely due to stochastic transgene expression, a relatively common phenomenon in transgenic mice (38). p300 ⌬flox is a null allele. The deletion efficiency in p300 flox/lflox ; Lck-Cre mice could be as high as ϳ90 to 95% and was specific for the thymus (L. H. Kasper, data not shown) (69) . Mice with high deletion frequencies were deficient for full-length p300 protein as measured by Western blots using thymic nuclear extracts and antibodies specific for the N terminus of p300 (Fig. 2c ). CBP protein levels were not measurably affected in the p300 null thymuses ( Fig. 2c; 3a ), nor were p300 protein levels altered in thymuses deficient for CBP (Fig.  3a) . There was no evidence for truncated forms of p300 appearing in p300 flox/lflox ; Lck-Cre thymic nuclear extracts as determined by Western blots using an N-terminus-specific antibody following 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, although a small amount of material that reacted with a C-terminal p300 antibody ran at the dye front (less than 37 kDa) (P. K. Brindle, data not shown). However, indirect immunofluorescence of thymocytes from p300 flox/flox ; LckCre and CBP flox/flox ; Lck-Cre mice using antibodies specific for the C termini of p300 or CBP confirmed that many cells lacked p300 or CBP, respectively (Fig. 3b) Quantitation of individual thymocyte subtypes showed that double-negative (DN) cell numbers (the least mature major subtype) were relatively unaffected in both mutants ( Fig. 4c and 5c), whereas there was a five-to threefold average decrease in double-positive (DP) cell numbers for CBP ( Fig. 4d ) (n ϭ 4) and p300 ( Fig. 5d ) (n ϭ 5) mutant mice, respectively, compared to flox controls (n ϭ 4 and 6, respectively). This apparent conflict with the relative increase in the percentage of DN cells seen by FACS ( Fig. 4a and 5a ) is explained by the decrease in thymus size for both CBP and p300 mutant mice. Since Lck-Cre transgene expression does not initiate until the DN1 stage (the least mature stage in the thymus), DN cell numbers may be normal ( Fig. 4c and 5c ) because loss of CBP or p300 has no effect on DN cells or, alternatively, because CBP and p300 protein and mRNA levels are not sufficiently depleted by turnover and dilution until the next stage of development (i.e., DP thymocytes).
SP cell numbers were generally decreased about twofold in the mutants compared to controls ( Fig. 4e and f and 5e and f), except that CBP flox/flox ; Lck-Cre mice had normal numbers of CD8 ϩ cells (Fig. 4f ). This indicates that the 10-fold increase in the percentage of CD8 ϩ SP cells in CBP flox/flox ; Lck-Cre thymuses ( Fig. 4a) was, in fact, due to a decrease in the absolute number of DP and CD4 ϩ SP cells. Given that thymocyte development occurs in a stepwise manner from DN to DP to SP, this would indicate that the "normal" levels of CD8
ϩ SP cells in CBP flox/flox ; Lck-Cre mice arise by an altered process, as they are derived from a much smaller pool of DP precursors than in control mice. By contrast, the ratio of CD4 ϩ to CD8 ϩ SP thymocytes in p300 flox/flox ; Lck-Cre mice was normal (Fig. 5a ).
We previously showed that CBP flox/flox ; MMTV-Cre mice had an increased percentage of CD8 ϩ SP thymocytes, although it was unclear if this defect was autonomous to the thymus because CBP flox inactivation occurred in multiple tissues (93 Fig. 4a; 5a) , even when deletion in the thymus was high (ϳ80 to 90%) ( Fig. 4b ; 5b), but there was a modest ϳ2-fold reduction in the number of peripheral blood CD4 ϩ (P ϭ 0.028, analysis of variance [ANOVA]) and CD8 ϩ (P ϭ 0.020) T cells in CBP flox/flox ; LckCre mice that was not observed in p300 flox/flox ; Lck-Cre mice (Fig. 6a) . Peripheral blood B-cell numbers were comparable between control and mutant mice, demonstrating the lineage specificity of the mutations (P ϭ 0.58, ANOVA) (Fig. 6b) .
Comparison of the deletion frequency in thymus and affinitypurified splenic T cells revealed that the fraction of cells harboring the nonrecombined alleles increased in peripheral T cells from p300 flox/flox ; Lck-Cre mice (Fig. 7a) and CBP flox/flox ; Lck-Cre mice (Fig. 7b) , indicating that late developmental stage or peripheral T cells with p300 or CBP deficiency are at a disadvantage.
Loss of p300 in thymocytes does not lead to lymphoma. We previously showed that CBP flox/flox ; MMTV-Cre mice develop T-cell lymphoma with high frequency starting at 3 months of age (93) . Since CBP and p300 functions are often interchangeable in vitro, we expected to see T-cell lymphoma develop in p300 flox/flox ; MMTV-Cre mice. Surprisingly, a cohort of 40 p300 flox/flox ; MMTV-Cre mice did not develop lymphoma out to 104 weeks of age (Fig. 8a) . By comparison, a cohort of 37 CBP flox/flox ; MMTV-Cre mice developed T-cell lymphoma with high frequency as early as 16 weeks (Fig. 8a ). We observed a comparable incidence and onset of T-cell lymphoma in CBP flox/flox ; Lck-Cre mice (Fig. 8b ) (P ϭ 0.03, one-tailed log rank test, n ϭ 25), although over time, the frequency of lymphoma dropped markedly as the mice were backcrossed, indicating that other genetic or environmental factors contribute to tumor development (T. Fukuyama, data not shown). We did not observe lymphoma in p300 flox/flox ; Lck-Cre mice out past 1 year of age ( ; Lck-Cre colonies, suggesting that environmental factors alone cannot account for the differences in tumor phenotype observed. Together, the data support the view that there are intrinsic differences in the tumor suppressor functions of CBP and p300, even though the contributing environmental and genetic factors required for T-cell lymphomagenesis in the absence of CBP are unclear and somewhat variable. In this regard, it has recently been shown that p300 levels can vary in different mouse strains, suggesting that the combined dosage of CBP and p300 protein may also fluctuate and lead to variable phenotypic penetrance (158) .
CBP and p300 combined dosage is critical for thymocyte development. The ability of T cells to develop and survive with only CBP or p300 raised the possibility that cells lacking both coactivators could be generated. We tested this by creating CBP flox/flox ; p300 flox/flox ; Lck-Cre mice ("quad" mutants). Recombination of the CBP flox allele could be detected in quad mutant thymuses by semiquantitative PCR (Fig. 9b ), albeit at a reduced level compared to CBP flox/flox ; Lck-Cre mice. Similar results were obtained for the p300 flox allele (Fig. 9b ) (PCR quantitation is fairly linear for CBP ⌬flox but tends to overestimate the relative abundance of the p300 ⌬flox allele; M. A. Biesen, data not shown).
FACS analysis of quad mutant mice with efficient recombination (ϳ50%) of the CBP flox and p300 flox alleles in the thymus revealed about a 10-fold increase in the percentage of DN thymocytes, with a concomitant decrease in DP cells; mice with a lower deletion frequency (ϳ30%) in the thymus had an both CBP and p300 are strongly selected against. We confirmed this by quantitating the number of thymocytes per subpopulation in quad mutants that showed both medium (ϳ50%) and low (ϳ10 to 30%) deletion frequencies. Total thymocyte counts decreased with increased deletion frequency, and as a result, DN cell numbers were unaffected in both classes of quad mutants compared to control mice (Fig. 10a) , but DP cells were reduced about 10-fold in thymuses displaying medium levels of deletion (Fig. 10b ). There was a deficiency of SP thymocytes in quad mutants with medium deletion, although the CD8 ϩ SP thymocytes were more variably affected ( Fig. 10c and d) . In further support of these data, genomic DNA isolated from FACS-purified quad mutant thymocyte subtypes showed ϳ30 to 40% deletion of the CBP flox and p300 flox alleles in DN cells, but there was a steady drop in the frequency of both recombined alleles in DP and SP thymocytes, with an almost complete absence (ϳ1% deletion) in peripheral T cells purified from the spleen and lymph nodes ( Fig. 11a and b) . These results indicate that thymocyte development requires either CBP or p300 and that T cells need CBP or p300 to populate the peripheral lymphoid organs. The numbers of T cells in the spleen and blood of quad mutants were not significantly different from those of control mice, however, indicating that there is compensation by homeostatic proliferation of peripheral T cells that did not recombine the alleles (Fig. 10e and f) (P Ͼ 0.05, ANOVA, n ϭ 3 to 9).
The model that concentrations of CBP and p300 are critically limiting predicts that a modest reduction (ϳ50%) in their combined levels will have catastrophic consequences for cells. In contrast, results from this study suggest a model where CBP and p300 are not extremely limiting and that lesser amounts (between 0 and 50%) of the coactivators can still support many critical functions. We compared these models by determining whether one CBP or p300 wild-type allele is sufficient for thymocyte development and for T cells to populate the periphery. Both CBP ϩ/flox ; p300 flox/flox ; Lck-Cre and CBP flox/flox ; p300 ϩ/flox ; Lck-Cre mice ("triple" mutants) were generated, and semiquantitative PCR analysis of thymic and T-cell genomic DNA was performed. In this instance, we corrected the PCR data by using a standard curve made with samples of known deletion frequency as determined by quantitative Southern blotting. The corrected PCR data demonstrated that triple-mutant cells of both genotypes were selected against in the periphery, although not to the extent seen with the quad mutants ( Fig. 12a  and b , note that the similarity in deletion frequency for both types of alleles indicates that an individual cell either recombines all the alleles or none; the quad mutant data in Fig. 11  corroborate this) . Remarkably, about 20 to 30% deletion was observed for both CBP flox and p300 flox in peripheral T cells of CBP ϩ/flox ; p300 flox/flox ; Lck-Cre mice, suggesting that T cells with one wild-type CBP allele may be able to develop and populate the lymphoid organs to some degree (Fig. 12b) 12a and c). All told, these results demonstrate that there is a graded effect of the combined dosage of functional CBP and p300 alleles on T-cell development and their ability to populate the periphery. The inactivation of both CBP alleles (along with one p300 allele) was more detrimental to peripheral T cells than the other triple mutation combination (compare Fig. 12a and c with 12b), which is consistent with our observation that CBP is more important for T cells than p300. Cre-mediated recombination, allowing us to sort for a population of splenic T cells with a high deletion frequency of CBP or p300 (143) . We used these cells to elucidate the role of CBP and p300 in gene expression in response to activation of signaling through the T-cell receptor (TCR). We tested two genes, interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-␣), whose expression in response to TCR signaling is critical for T-cell function and has been reported to involve p300 and CBP (47, 228). IL-2 mRNA expression was reduced less than twofold in CBP flox/flox ; Lck-Cre cells and was unaffected in p300 flox/flox ; Lck-Cre splenic T cells in response to treatment with PMA and calcium ionophore. The decrease in IL-2 may be due to the increased fraction of CD8 ϩ T cells relative to CD4 ϩ cells in the spleen (Fig. 4a) , as not all CD8 ϩ -T-cell subtypes express IL-2 efficiently (212). TNF-␣ mRNA expression, however, was decreased more than twofold in p300 flox/flox ; Lck-Cre and more than fourfold in CBP flox/flox ; Lck-Cre in activated splenic T cells (Fig. 13a and b) . This deficit in TNF-␣ expression is in agreement with a previous report by Falvo et al. demonstrating that CBP null heterozygous T cells are defective in TNF-␣ expression in response to TCR activation with anti-CD3 and suggests that p300 is also important (47).
Gene expression in CBP and p300 null macrophages. We used bone marrow-derived macrophages to further investigate the effects of CBP and p300 deficiency on endogenous signalresponsive gene expression. We chose several cytokine-and Toll-like receptor (TLR)-responsive target genes where either CBP or p300 has been previously implicated as playing a key role in expression or a presumed role based on chromatin immunoprecipitation assays. TNF-␣, arginase (Arg1), inducible nitric oxide synthase (iNOS), and interferon regulatory factor 1 (IRF-1), are regulated by gene-specific combinations of the CBP/p300-interacting transcription factors ATF-2, cJun, SP1, Ets, Egr-1, NF-B, AP-1, STAT1, PU.1, STAT6, and C/EBP␤ (Fig. 1) (9, 117, 152) . CBP flox/flox ; lysMcre mice that express Cre in macrophages yielded cells with an ϳ80 to 90% reduction in CBP protein when measured by Western blotting of nuclear extracts (Fig. 14a) (32) . Northern blot analysis revealed that TNF-␣ mRNA was robustly induced in response to lipopolysaccharide (LPS) stimulation in CBP flox/flox ; lysMcre macrophages, although not quite as well as in control CBP flox/flox cells (Fig. 14b) (rRNA served as a loading control). Arginase (Arg1) induction in response to the cytokine IL-4 was measured by Western blotting and was comparable between CBP flox/flox ; lysMcre and CBP flox/flox macrophages (Fig. 14c ) (the nonspecific band serves as a loading control).
We next examined gene expression in macrophages deficient for p300. Recombination of the p300 flox allele in p300 flox/flox ; lysMcre macrophages was confirmed by semiquantitative PCR of genomic DNA (Fig. 14a) . TNF-␣ mRNA was induced comparably by LPS in p300 flox/flox and p300 flox/flox ; lysMcre macrophages (Fig. 14d, rRNA loading control in bottom panel) . Arg1 induction after IL-4 stimulation was also comparable between p300 flox/flox and p300 flox/flox ; lysMcre macrophages (Fig.  14e) , although treatment with both gamma interferon (IFN-␥) and LPS revealed a modest deficit in the kinetics of iNOS expression but not IRF-1 (Fig. 14f, nonspecific 
, and CD8 ϩ SP (CD8 ϩ SP) thymocyte subpopulations and affinity-purified T cells from spleen and lymph node (LN). T cells from spleen and LN were purified by positive selection using Thy1.2 ϩ -conjugated magnetic beads. PCR tends to overestimate the relative abundance of the p300 ⌬flox allele but is fairly quantitative for CBP ⌬flox . Numbers indicate the approximate deletion percentages; p300 values were corrected by comparison to a standard curve of known deletion frequency derived from Southern analysis. Cells were treated ex vivo with 1 ng/ml PMA and 200 ng/ml calcium ionophore (Iono) for 3 h, and qRT-PCR was performed to determine mRNA expression of IL-2 (a) and TNF-␣ (b). Expression was normalized to GAPDH expression, and treated control cells were arbitrarily set to 100 in each experiment. Graphs represent the average results from two independent experiments using cells from two different mice of each genotype (n ϭ 2).
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CONDITIONAL KNOCKOUT OF CBP AND p300 IN MICE 801 normal range (P. J. Murray, data not shown). Together, these results indicate that CBP or p300 individually is not highly limiting for TNF-␣ and Arg1 expression in macrophages in response to LPS and IL-4. Interestingly, iNOS, but not IRF-1, induction in response to IFN-␥ plus LPS appears to be partially sensitive to p300 deficiency, consistent with a proposed model that CBP and p300 are limiting for iNOS transcription (117). Induction of high-level iNOS expression requires IRF-1 and NF-B activity, so it appears that p300 levels are important for this process but expression levels can be compensated for by CBP or other factors. We did not observe a noticeable defect in TNF-␣ induction in macrophages even though both CBP and p300 null T cells showed a clear deficit (Fig. 13b) and B cells deficient for p300 or CBP showed a 30 to 60% decrease in TNF-␣ expression in response to B-cell receptor signaling (P. K. Brindle, submitted for publication). This may reflect differ- ent transcriptional regulator usage in the three cell types. It is worth noting that the macrophages tested here had less than 100% inactivation of CBP flox or p300 flox , so it is possible that contributions to gene expression by CBP or p300 were underestimated in this analysis.
DISCUSSION
Inactivation of either CBP or p300 starting at the DN stage of thymocyte development reduced, but did not completely block, the ability of T cells to populate the periphery; whereas, inactivation of all four CBP and p300 alleles had strong negative effects on T-cell development in the thymus. In addition, the aberrant increase in the percentage of CD8 ϩ SP thymocytes seen in CBP flox/flox ; Lck-Cre mice was not observed in p300 flox/flox ; Lck-Cre animals, indicating that CBP and p300 have nonredundant roles in T-cell development. Although the absolute levels of CBP and p300 protein are unknown, thymocytes express both proteins, which implies that large differences in expression do not account for the phenotypes. A provocative possibility is that differences in the biochemical properties of CBP and p300 are fundamental to the production of normal T cells and may also explain why loss of CBP, but not p300, in T cells can result in lymphoma.
Homeostatic proliferative mechanisms largely compensated for any reduction in the number of naive peripheral T cells caused by the mutations by allowing cells that did not recombine the conditional alleles (likely due to stochastic expression of the Lck-Cre transgene) to expand and fill the niche (84) . It is somewhat counterintuitive that loss of both CBP and p300 did not cause a significant decrease in peripheral T cells, even though loss of CBP alone caused a modest ϳ2-fold deficit. There are several possible explanations for this observation. It was surprising that loss of either CBP or p300 alone did not result in a more drastic T-cell phenotype given that the two coactivators have been shown to interact in vitro with over 190 proteins encoded by essential genes in mice, of which at least 56 are crucial for T cells (Mouse Genome Informatics) (Fig. 1) . It is possible that these two coactivators are not generally limiting in cells to the extent previously believed (64, 115, 203) . Indeed, CBP Ϫ/Ϫ and p300 Ϫ/Ϫ mice are viable through the first half of development (dying at E9 to E11.5), suggestive of three possibilities with regard to the in vivo roles of CBP and p300.
(i) In vitro interactions with CBP and p300 may not be biologically relevant. Our findings, however, argue that CBP and p300 interactions based upon in vitro evidence cannot be dismissed out of hand. Although HDM2 appears to aggregate nonspecifically with the unfolded TAZ1 domain of p300 in the presence of EDTA (131), we have found that three essential transcription factors (CREB, c-Myb, and HIF-1␣) with wellcharacterized in vitro interactions with CBP and p300 show partial loss of activity when CBP and p300 functionality is attenuated by mutation in primary cells or mice (95; Kasper et al., in press). (ii) CBP and p300 may function redundantly in most instances and be generally nonlimiting in many cell types. Support for the second point is self-evident, since many T cells can develop and survive and mice can go through a substantial portion of development with either CBP or p300 alone. In addition, we have not observed increased expression of remaining wild-type alleles as a possible compensatory mechanism in mutant cells, so it appears that CBP and p300 levels are not highly limiting for some of their functions. Nevertheless, there are differences in the phenotypes of the various CBP and p300 mutant mice created to date, making it clear that there are either unique biochemical properties for each coactivator or that some cell types have a skewed ratio of CBP to p300 that makes one of them limiting upon mutation. (iii) Other transcriptional cofactors that are not highly related to CBP and p300 may supply redundant functions (e.g., other proteins that have histone acetyltransferase activity and bromodomains such as Gcn5, P/CAF, and TAF1). This point raises the prospect that coactivator networks are more broadly interconnected and robust than typically understood. But there are obviously limits to this proposition, as our studies show that either CBP or p300 is absolutely essential because T cells lacking both are not viable. So other cofactors may only be able to compensate under a limited number of situations. The identities of such factors are unknown, although recent genetic studies demonstrate that the combined dosage of various histone acetyltransferase proteins harboring bromodomains (p300 and Gcn5, and p300 and P/CAF) are not generally limiting for mouse development (158) .
The creation of CBP flox and p300 flox mice will now permit researchers to rigorously test whether either member of this small coactivator family is critical in specific cell lineages in vivo and to test their roles in endogenous gene expression ex vivo. Such analyses would be facilitated by the use of a Cre recombination-dependent GFP indicator allele to enable the FACS purification of cells with high frequencies (Ͼ90%) of floxed gene inactivation for functional and transcriptional studies ex vivo (143). 
